Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Lifting of FDA Ban on Silicone Implants Boosts Sales in U.S. Medical Silicones Market - New analysis from Frost & Sullivan, U.S. Medical Silicones Market, reveals that the market earned revenues of $208.6 million in 2006 and estimates this to reach $409.5 million in 2013
Lifting of FDA Ban on Silicone Implants Boosts Sales in U.S. Medical Silicones Market

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2007/07/25 - New analysis from Frost & Sullivan, U.S. Medical Silicones Market, reveals that the market earned revenues of $208.6 million in 2006 and estimates this to reach $409.5 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With the U.S. Food and Drug Administration (FDA) ending the 14-year ban on silicone implants on November 17, 2006, the medical silicones market is witnessing remarkable growth. Moreover, silicone’s superior properties, when compared to other polymers used in implants, can encourage steady future growth.

New analysis from Frost & Sullivan (chemicals.frost.com), U.S. Medical Silicones Market, reveals that the market earned revenues of $208.6 million in 2006 and estimates this to reach $409.5 million in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the U.S. Medical Silicones Market, send an email to Vanessa Quezada, Corporate Communications, at vanessa.quezada[.]frost.com with your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information through email upon receipt of the above information.

Silicones can withstand a wider range of temperature, from 750 degrees Fahrenheit to 5,000 degrees Fahrenheit, and bear high resistance to water and many other chemicals. Moreover, their high tear and tensile strength properties make silicones extremely flexible.

Other salient features are that silicones are odorless, tasteless, bacterial resistant, and exhibit superior compatibility with human body. All these factors make silicones highly biocompatible and biodurable when compared to other materials. With such advanced properties, silicones are replacing other polymers in medical devices.

Furthermore, extensive diversity of requirements for medical devices has led to different types of silicone formulations.

However, the medical silicone market, a niche market, is presently facing challenges such as increasing energy costs and new technological developments.

“As the medical device industry continues to witness improvement of product designs in terms of patient comfort, functionality, ergonomics, and styling, this market is experiencing continuous modification and development,” observes Frost & Sullivan Research Analyst Urmila Kishore. “While product innovation is essential as it enhances performance capabilities and also improves safety of the medical devices, it also provides opportunities for the growth with changing requirements.”

The success of a company primarily depends on the investment in innovative technology. Therefore, it is necessary to have consistent product innovation.

“In an industry highly driven by safety regulations and policies, investment in medical engineering is paramount to have an edge in this fiercely competitive space,” notes Urmila.

Medical device manufacturers are constantly looking for means to differentiate their product offerings, since this will enable them to sustain their market leadership and also help them gain a significant advantage over their competitors. As a result silicone producers are likely to deliver highly versatile material solutions. Silicone producers need to have a broad range of silicone materials to ensure consistent and scalable business processes.

U.S. Medical Silicones Market is part of the Chemicals and Materials Growth Partnership Service Program. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership service, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Lifting of FDA Ban on Silicone Implants Boosts Sales in U.S. Medical Silicones Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Vanessa Quezada 
210.477.8427 vanessa.quezada[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today